Rosanna Asselta1, Elvezia M Paraboschi1, Alessio Gerussi2, Heather J Cordell3, George F Mells4, Richard N Sandford4, David E Jones5, Minoru Nakamura6, Kazuko Ueno7, Yuki Hitomi8, Minae Kawashima8, Nao Nishida8, Katsushi Tokunaga9, Masao Nagasaki10, Atsushi Tanaka11, Ruqi Tang12, Zhiqiang Li13, Yongyong Shi13, Xiangdong Liu14, Ma Xiong12, Gideon Hirschfield15, Katherine A Siminovitch16, Marco Carbone2, Giulia Cardamone1, Stefano Duga1, M Eric Gershwin17, Michael F Seldin17, Pietro Invernizzi18. 1. Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy. 2. Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; European Reference Network on Hepatological Diseases, San Gerardo Hospital, Monza, Italy. 3. Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, United Kingdom. 4. Academic Department of Medical Genetics, Cambridge University, Cambridge, United Kingdom. 5. Faculty of Medical Sciences, Newcastle University, Newcastle, United Kingdom. 6. Clinical Research Center, National Hospital Organization, Nagasaki Medical Center, Nagasaki, Japan; Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Omura, Nagasaki, Japan. 7. Genome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan. 8. Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 9. Genome Medical Science Project, National Center for Global Health and Medicine, Tokyo, Japan; Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. 10. Human Biosciences Unit for the Top Global Course Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. 11. Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan. 12. Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China. 13. Affiliated Hospital of Qingdao University and Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China. 14. Key Laboratory of Developmental Genes and Human Diseases, Institute of Life Sciences, Southeast University, Nanjing, Jiangsu, China. 15. Toronto General Hospital Research Institute, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 16. Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Mount Sinai Hospital, Lunenfeld Tanenbaum Research Institute and Toronto General Research Institute, Toronto, Canada; Department of Immunology, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada. 17. University of California-Davis, Davis, California. 18. Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; European Reference Network on Hepatological Diseases, San Gerardo Hospital, Monza, Italy. Electronic address: pietro.invernizzi@unimib.it.
Abstract
BACKGROUND & AIMS: Genome-wide association studies in primary biliary cholangitis (PBC) have failed to find X chromosome (chrX) variants associated with the disease. Here, we specifically explore the chrX contribution to PBC, a sexually dimorphic complex autoimmune disease. METHODS: We performed a chrX-wide association study, including genotype data from 5 genome-wide association studies (from Italy, United Kingdom, Canada, China, and Japan; 5244 case patients and 11,875 control individuals). RESULTS: Single-marker association analyses found approximately 100 loci displaying P < 5 × 10-4, with the most significant being a signal within the OTUD5 gene (rs3027490; P = 4.80 × 10-6; odds ratio [OR], 1.39; 95% confidence interval [CI], 1.028-1.88; Japanese cohort). Although the transethnic meta-analysis evidenced only a suggestive signal (rs2239452, mapping within the PIM2 gene; OR, 1.17; 95% CI, 1.09-1.26; P = 9.93 × 10-8), the population-specific meta-analysis showed a genome-wide significant locus in East Asian individuals pointing to the same region (rs7059064, mapping within the GRIPAP1 gene; P = 6.2 × 10-9; OR, 1.33; 95% CI, 1.21-1.46). Indeed, rs7059064 tags a unique linkage disequilibrium block including 7 genes: TIMM17B, PQBP1, PIM2, SLC35A2, OTUD5, KCND1, and GRIPAP1, as well as a superenhancer (GH0XJ048933 within OTUD5) targeting all these genes. GH0XJ048933 is also predicted to target FOXP3, the main T-regulatory cell lineage specification factor. Consistently, OTUD5 and FOXP3 RNA levels were up-regulated in PBC case patients (1.75- and 1.64-fold, respectively). CONCLUSIONS: This work represents the first comprehensive study, to our knowledge, of the chrX contribution to the genetics of an autoimmune liver disease and shows a novel PBC-related genome-wide significant locus.
BACKGROUND & AIMS: Genome-wide association studies in primary biliary cholangitis (PBC) have failed to find X chromosome (chrX) variants associated with the disease. Here, we specifically explore the chrX contribution to PBC, a sexually dimorphic complex autoimmune disease. METHODS: We performed a chrX-wide association study, including genotype data from 5 genome-wide association studies (from Italy, United Kingdom, Canada, China, and Japan; 5244 case patients and 11,875 control individuals). RESULTS: Single-marker association analyses found approximately 100 loci displaying P < 5 × 10-4, with the most significant being a signal within the OTUD5 gene (rs3027490; P = 4.80 × 10-6; odds ratio [OR], 1.39; 95% confidence interval [CI], 1.028-1.88; Japanese cohort). Although the transethnic meta-analysis evidenced only a suggestive signal (rs2239452, mapping within the PIM2 gene; OR, 1.17; 95% CI, 1.09-1.26; P = 9.93 × 10-8), the population-specific meta-analysis showed a genome-wide significant locus in East Asian individuals pointing to the same region (rs7059064, mapping within the GRIPAP1 gene; P = 6.2 × 10-9; OR, 1.33; 95% CI, 1.21-1.46). Indeed, rs7059064 tags a unique linkage disequilibrium block including 7 genes: TIMM17B, PQBP1, PIM2, SLC35A2, OTUD5, KCND1, and GRIPAP1, as well as a superenhancer (GH0XJ048933 within OTUD5) targeting all these genes. GH0XJ048933 is also predicted to target FOXP3, the main T-regulatory cell lineage specification factor. Consistently, OTUD5 and FOXP3 RNA levels were up-regulated in PBC case patients (1.75- and 1.64-fold, respectively). CONCLUSIONS: This work represents the first comprehensive study, to our knowledge, of the chrX contribution to the genetics of an autoimmune liver disease and shows a novel PBC-related genome-wide significant locus.
Authors: Keith D Lindor; M Eric Gershwin; Raoul Poupon; Marshall Kaplan; Nora V Bergasa; E Jenny Heathcote Journal: Hepatology Date: 2009-07 Impact factor: 17.425
Authors: Yitan Zhu; Yanxun Xu; Donald L Helseth; Kamalakar Gulukota; Shengjie Yang; Lorenzo L Pesce; Riten Mitra; Peter Müller; Subhajit Sengupta; Wentian Guo; Jonathan C Silverstein; Ian Foster; Nigel Parsad; Kevin P White; Yuan Ji Journal: J Natl Cancer Inst Date: 2015-05-08 Impact factor: 13.506
Authors: Xiangdong Liu; Pietro Invernizzi; Yue Lu; Roman Kosoy; Yan Lu; Ilaria Bianchi; Mauro Podda; Chun Xu; Gang Xie; Fabio Macciardi; Carlo Selmi; Sara Lupoli; Russell Shigeta; Michael Ransom; Ana Lleo; Annette T Lee; Andrew L Mason; Robert P Myers; Kevork M Peltekian; Cameron N Ghent; Francesca Bernuzzi; Massimo Zuin; Floriano Rosina; Elisabetta Borghesio; Annarosa Floreani; Roberta Lazzari; Grazia Niro; Angelo Andriulli; Luigi Muratori; Paolo Muratori; Piero L Almasio; Pietro Andreone; Marzia Margotti; Maurizia Brunetto; Barbara Coco; Domenico Alvaro; Maria C Bragazzi; Fabio Marra; Alessandro Pisano; Cristina Rigamonti; Massimo Colombo; Marco Marzioni; Antonio Benedetti; Luca Fabris; Mario Strazzabosco; Piero Portincasa; Vincenzo O Palmieri; Claudio Tiribelli; Lory Croce; Savino Bruno; Sonia Rossi; Maria Vinci; Cleofe Prisco; Alberto Mattalia; Pierluigi Toniutto; Antonio Picciotto; Andrea Galli; Carlo Ferrari; Silvia Colombo; Giovanni Casella; Lorenzo Morini; Nicola Caporaso; Agostino Colli; Giancarlo Spinzi; Renzo Montanari; Peter K Gregersen; E Jenny Heathcote; Gideon M Hirschfield; Katherine A Siminovitch; Christopher I Amos; M Eric Gershwin; Michael F Seldin Journal: Nat Genet Date: 2010-07-18 Impact factor: 38.330